|
Express Coding Webinar: Coding Complex Surgical Cases |
|
Enduring |
|
$0.00 |
|
When to Operate and When to Hesitate: Safety and Surgical Considerations for Gynecologic Oncologists During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
Infusion Confusion: COVID-19 and Anti-Cancer Treatments and Clinical Trial Considerations for Gynecologic Oncology Patients |
|
Enduring |
|
$0.00 |
|
Crucial Conversations and Managing Pandemic Panic |
|
Enduring |
|
$0.00 |
|
Educating Your Trainee During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
Telemedicine for Gynecologic Oncology Care During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
Ethical Considerations and Critical Communication During COVID-19 |
|
Enduring |
|
$0.00 |
|
Surgical Safety, Testing, and Triage Considerations During the COVID-19 Pandemic |
|
Enduring |
|
$0.00 |
|
Health Equity in the COVID-19 Era: Understanding the Data and Strategies to Support Vulnerable Populations |
|
Enduring |
|
$0.00 |
|
Front Line Ovarian Cancer: Turning Up The Heat on Immunotherapy - 2020 Annual Meeting Webinar Series |
|
Enduring |
|
$0.00 |
|
PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers |
|
Enduring |
|
$0.00 |
|
2020 Annual Meeting Webinar Series |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Evaluation and Management Coding for 2021 |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Immunotherapy Toxicity |
|
Enduring |
|
$0.00 |
|
Turnover Talk: Novel Discoveries in Endometrial Cancer: Are we finally making progress? |
|
Enduring |
|
$0.00 |
Facebook
Twitter
LinkedIn
Forward